A prototype blood-based screening test evaluated by Cleveland Clinic researchers and others can accurately detect and localize multiple types of cancer, often before symptoms show. The promising results raise hopes that the assay will help achieve the long-sought goal of population-scale early detection of cancer.
Patterns of DNA Methylation May Differentiate Indolent and Aggressive Prostate Cancers
Differences between indolent and aggressive forms of prostate cancer have been identified based on patterns of DNA methylation according to researchers Lerner Research Institute of the Cleveland Clinic.